0      0


240 - Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment


‐ Oct 1, 2022 12:15pm


Credits: None available.

Sponsored by Urovant Sciences


Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.